JESSICA SZCZERBA: Open Payments
NPI 1760934160 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 21 payments from 3 companies in 2025. Trend: 2023 $191 · 2024 $125 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $403 |
| Travere Therapeutics, Inc. | 13 | $196 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $94 |
Products named: Fabhalta, ADAKVEO, Vanrafia.
Industry payments across NY — which companies pay providers there.
